Melissa B. Epperly, Chief Financial Officer at Zentalis Pharmaceuticals, Inc. (ZNTL), sold 4,608 shares at $51.33 ($237K) on 2020-12-02, disclosed to the SEC on 2020-12-03.
Open-market sale of $237k ZNTL by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.34 | 700 | $35K | 14.9% |
| 2 | $51.33 | 1,525 | $78K | 33.0% |
| 3 | $51.33 | 1,525 | $78K | 33.0% |
| 4 | $52.27 | 500 | $26K | 11.0% |
| 5 | $53.17 | 358 | $19K | 8.0% |
| Total | $51.42 avg | 4,608 |
| $237K |
| 100% |
| Filing → |
| ROIV | SELL | 2026-07-01 | $610K | — | Filing → |
| ROIV | SELL | 2026-03-18 | $1.2M | — | Filing → |
| ZNTL | SELL | 2024-02-12 | $29K | — | Filing → |